Description
An NSAID and selective COX-2 inhibitor (IC50s = 0.63 and 23 μM for COX-2 and COX-1, respectively); increases weight bearing and decreases lameness and joint effusion in a canine model of urate crystal-induced intraarticular synovitis; induces less lesion formation in the gastric mucosa of healthy canines than aspirin at 1.5 mg/kg
Formal name: 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]-benzenesulfonamide
Synonyms: SC-59046
Molecular weight: 397.4
CAS: 169590-41-4
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Small Molecule Inhibitors|Cyclooxygenases||Research Area|Immunology & Inflammation|Arthritis (Non-autoimmune)||Research Area|Neuroscience|Pain Research